Found 15 matching trials
Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study) PHASE4 The main goal of this study is to compare the Haemophilus influenzae type b...
Show More Location
Alaska Native Medical Center
Learn More & Join Trial
Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine PHASE3 The purpose of this study is to evaluate the safety, tolerability, and immu...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) PHASE3 This is a study to assess the safety, tolerability, and immunogenicity of V...
Show More Location
Multiple Locations
Learn More & Join Trial
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines PHASE2 This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age PHASE3 The primary phase of this study is evaluating the safety of Hib-MenCY-TT va...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine PHASE3 This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age PHASE3 The purpose of this study is to evaluate the safety, reactogenicity and imm...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) PHASE2 The purpose of this study is to evaluate the safety, tolerability and immun...
Show More Location
Multiple Locations
Learn More & Join Trial
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068) PHASE4 This two-stage study evaluates the immunogenicity, safety, and tolerability...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) PHASE3 To determine if there is an improvement in the immune response to HBsAg (he...
Show More Location
Multiple Locations
Learn More & Join Trial